NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness.
NEW YORK (GenomeWeb) – Enigma Diagnostics today said that it will collaborate with China’s National Institute for Communicable Disease Control and Prevention on the development of rapid molecular diagnostics for infectious disease pathogens.
NEW YORK (GenomeWeb News) – Enigma Diagnostics today announced a second grant from the UK's Technology Strategy Board to further develop the company's multidrug-resistant tuberculosis (MDR-TB) test on its Enigma Mini Laboratory system.
BioFire Diagnostics said this week that it has commenced clinical and analytical studies to evaluate its FilmArray Gastrointestinal Panel with plans to seek both CE IVD marking and US Food and Drug Administration clearance.
NEW YORK (GenomeWeb News) – Enigma Diagnostics this week said that it has received a Biomedical Catalyst grant from the UK government to support further development of multiplexed PCR assays using the firm's ResonSense probing technology.